November-December 2014: Volume 15 Number 11/12
1 December 2014. Related: Editorial.
2014
ARV supply issues cause treatment interruptions in a UK clinic
1 December 2014. Related: Treatment alerts.
12th Glasgow Congress on HIV Therapy, 2-6 November 2014, Glasgow
1 December 2014. Related: Conference reports.
Savings to the NHS predicted from switching to generic antiretrovirals
1 December 2014. Related: Conference reports, Antiretrovirals, Treatment access.
Lower dose efavirenz effective in two studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Should tenofovir dose be 200 – 250 mg when used with protease inhibitors?
1 December 2014. Related: Conference reports, Antiretrovirals.
3TC inferior to FTC in Dutch cohort but interchangeable in other studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Suicide not associated with efavirenz use in the D:A:D cohort study
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Gender differences in use of cardiovascular disease-related interventions: D:A:D study
1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.
Efavirenz decreases exposure to hormonal contraceptive implant
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Increased risk of ART-related hepatotoxicity in HIV positive pregnant women
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.
Darunavir pharmacokinetics in pregnancy and postpartum
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
BHIVA Autumn Conference, 9-10 October 2014, London
1 December 2014. Related: Conference reports.
Good management of HIV positive pregnant women in UK – with some room for improvement
1 December 2014. Related: Conference reports, Pregnancy.
Southern African Clinicians Society Conference, 24-27 September 2014, Cape Town, South Africa
1 December 2014. Related: Conference reports.
Efavirenz-associated gynaecomastia reported to the national HIV and TB healthcare workers hotline in South Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Infants start ART too late but improvement over time in Southern Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Treatment outcomes in HIV positive and negative people with drug resistant TB in Khayelitsha, Cape Town
1 December 2014. Related: Conference reports, TB coinfection.
Pregnancy a risk factor for poor antiretroviral treatment outcomes in South African adolescents
1 December 2014. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Poppers-related maculopathy linked to permanent and serious vision loss
1 December 2014. Related: Side effects.
Equivalent efficacy with lower dose darunavir
1 December 2014. Related: Antiretrovirals, PK and drug interactions.
US activists called on Gilead to set a per-treatment price for sofosbuvir/ledipasvir
1 December 2014. Related: Hepatitis coinfection.
UK PROUD study to provide PrEP to all participants earlier than expected: planned follow-up to continue to two years
1 December 2014. Related: HIV prevention and transmission.
IPERGAY PrEP study shows early efficacy in protecting gay men from HIV: all participants to switch to active drug
1 December 2014. Related: HIV prevention and transmission.
Three papers on macrophages and HIV infection
1 December 2014. Related: Cure-related research, Basic science and immunology.
HIV in the UK 2014: Public Health England report on incidence and care
1 December 2014. Related: HIV prevention and transmission, Other news.
Conferences
1 December 2014. Related: On the web.
Online article
1 December 2014. Related: On the web.
November/December 2014: Volume 15 Number 11/12
1 December 2014. Related: PDFs.
UK PROUD study to provide PrEP earlier than expected: planned follow-up to continue to two years
16 October 2014. Related: HIV prevention and transmission, Research studies.
September/October 2014: Volume 15 Number 9/10
1 October 2014. Related: Editorial.
54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 5-9 September 2014, Washington, DC
1 October 2014. Related: Conference reports.
Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP
1 October 2014. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Switch from efavirenz to rilpivirine quells CNS toxicity, improves sleep
1 October 2014. Related: Conference reports, Antiretrovirals.
HIV persists in lung macrophages of people on suppressive ART
1 October 2014. Related: Conference reports, Antiretrovirals, Cure-related research.
Only 10% of veterans with HCV or HCV/HIV in the US treated for HCV
1 October 2014. Related: Conference reports, Hepatitis coinfection.
20th International AIDS Conference, 20-25 July 2014, Melbourne
1 October 2014. Related: Conference reports.
Update on baseline STIs in UK oral PrEP study (PROUD)
1 October 2014. Related: Conference reports, HIV prevention and transmission.
High prevalence of COPD at baseline in START study sub-study
1 October 2014. Related: Conference reports, Coinfections and complications.
Risk of CVD or type-2 diabetes according to change in BMI after starting ART
1 October 2014. Related: Conference reports, Antiretrovirals, Side effects.
Rosuvastatin may be partially effective in moderating residual immune activation on ART
1 October 2014. Related: Conference reports, Side effects.
Reasons for loss to follow up in the Malawi Option B+ programme
1 October 2014. Related: Conference reports, Pregnancy.
Single-pill dolutegravir/abacavir/3TC (Triumeq) approved in EU and US
1 October 2014. Related: Antiretrovirals.
Cobicistat and elvitegravir approved in the US as single pills
1 October 2014. Related: Antiretrovirals.
Positive opinion to approve of darunavir/cobicistat in Europe
1 October 2014. Related: Antiretrovirals.
UK updates PEP guidelines (2014): raltegravir replaces PIs and no indication if positive partner has an undetectable viral load
1 October 2014. Related: Guidelines.
BHIVA pregnancy guidelines: 2014 interim update
1 October 2014. Related: Pregnancy, Guidelines.
US HIV guidelines for management of chronic kidney disease (IDSA, 2014)
1 October 2014. Related: Guidelines.
Raltegravir pharmacokinetics in pregnancy and neonates
1 October 2014. Related: Pregnancy.
Efavirenz pharmacokinetics among pregnant women with and without tuberculosis coinfection
1 October 2014. Related: Pregnancy, TB coinfection.
Immunotherapy for PML: two case reports using IL-7 and experimental recombinant JCV VP1 protein therapeutic vaccination
1 October 2014. Related: Coinfections and complications.
Kidney signal trouble worsens over 5 years in Japanese on tenofovir
1 October 2014. Related: Side effects, Coinfections and complications.
Case report: Stem cell transplantation from CCR5 delta-32 homozygous donor selects for X4-tropic HIV
1 October 2014. Related: Cure-related research.
HIV reinfection has limited impact on disease progression
1 October 2014. Related: HIV prevention and transmission.
Stemming the flow from HIV reservoirs with neutralising antibodies
1 October 2014. Related: Cure-related research, Basic science and immunology.
Daclatasvir approved in EU for HCV genotypes 1-4
1 October 2014. Related: Hepatitis coinfection.
CHMP gives positive opinion to approve coformulated sofosbuvir/ledipasvir
1 October 2014. Related: Hepatitis coinfection.
European activists protest at meeting of European Health Ministers for access to new HCV drugs
1 October 2014. Related: Hepatitis coinfection.
DSMB open report strongly supports importance of START study
1 October 2014. Related: Other news.
September/October 2014: Volume 15 Number 9/10 – PDF
1 October 2014. Related: PDFs.
July/August 2014: Volume 15 Number 7/8
1 August 2014. Related: Editorial.
20th International AIDS Conference, 20-25 July 2014, Melbourne
1 August 2014. Related: Conference reports.
The loss of friends and colleagues from flight MH 17
1 August 2014. Related: Conference reports.
Higher ART coverage is associated with lower HIV infection rates in a multi-country analysis
1 August 2014. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Pill A, Pill B: simplified second-line treatment for low-income countries
1 August 2014. Related: Conference reports, Antiretrovirals, Treatment access.